Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BAPTIST HEALTH REGIONAL HOSPITALS

NPI: 1154807584 · VAN BUREN, AR 72956 · Rehabilitation Clinic/Center · NPI assigned 07/18/2018

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WELLS, TROY controls 20+ related entities in our dataset. Read more

$2.46M
Total Medicaid Paid
126,877
Total Claims
106,607
Beneficiaries
130
Codes Billed
2018-11
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWELLS, TROY (PRESIDENT)
NPI Enumeration Date07/18/2018

Related Entities

Other providers sharing the same authorized official: WELLS, TROY

ProviderCityStateTotal Paid
BAPTIST HEALTH REGIONAL HOSPITALS FORT SMITH AR $17.49M
BAPTIST HEALTH LITTLE ROCK AR $16.48M
BAPTIST HEALTH NORTH LITTLE ROCK AR $14.02M
BAPTIST HEALTH ARKADELPHIA AR $4.82M
CONWAY COMMUNITY SERVICES CONWAY AR $4.12M
BAPTIST HEALTH HEBER SPRINGS AR $3.69M
BAPTIST HEALTH HOSPITALS STUTTGART AR $2.97M
BAPTIST HEALTH LITTLE ROCK AR $2.93M
BAPTIST HEALTH MALVERN AR $2.68M
BAPTIST HEALTH LITTLE ROCK AR $1.83M
BAPTIST HEALTH ARKADELPHIA AR $1.51M
BAPTIST HEALTH HOSPITALS STUTTGART AR $901K
BAPTIST HEALTH LITTLE ROCK AR $780K
BAPTIST HEALTH NORTH LITTLE ROCK AR $411K
BAPTIST HEALTH MONTICELLO AR $367K
BAPTIST HEALTH CONWAY AR $142K
BAPTIST HEALTH LITTLE ROCK AR $88K
BAPTIST HEALTH PRESCOTT AR $33K
BAPTIST HEALTH MALVERN AR $31K
BAPTIST HEALTH HEBER SPRINGS AR $22K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,521 $67K
2019 27,886 $375K
2020 16,024 $214K
2021 19,776 $348K
2022 23,172 $500K
2023 21,478 $575K
2024 15,020 $378K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 4,408 4,143 $490K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,922 1,733 $303K
70450 Computed tomography, head or brain; without contrast material 2,048 1,810 $220K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3,793 1,014 $149K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2,778 2,598 $131K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,279 1,149 $94K
80048 Basic metabolic panel (calcium, ionized) 5,651 4,884 $89K
80053 Comprehensive metabolic panel 4,508 3,736 $75K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 9,071 7,535 $69K
71045 Radiologic examination, chest; single view 5,656 5,034 $60K
36415 Collection of venous blood by venipuncture 6,803 5,872 $49K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,035 894 $46K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 4,037 3,436 $44K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 469 444 $41K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 350 311 $34K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4,153 3,544 $30K
81025 3,376 3,048 $29K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,279 1,094 $28K
71046 Radiologic examination, chest; 2 views 1,339 1,117 $25K
86710 1,125 664 $24K
73630 719 646 $23K
81001 5,338 4,624 $22K
12001 97 86 $21K
84484 2,717 2,119 $21K
83690 2,810 2,452 $21K
73130 623 539 $15K
73610 774 686 $14K
80076 1,146 1,040 $14K
99283 Emergency department visit for the evaluation and management, moderate severity 728 652 $14K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 53 52 $12K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 260 187 $11K
80305 801 726 $11K
87088 1,006 890 $10K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 829 764 $10K
73110 418 350 $9K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,606 2,340 $9K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 86 64 $9K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,783 1,398 $8K
81003 2,665 2,384 $8K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,728 1,505 $7K
87430 751 597 $7K
85027 1,162 992 $7K
31720 28 28 $6K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 4,026 3,745 $6K
82150 989 853 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,855 2,444 $6K
96361 Intravenous infusion, hydration; each additional hour 1,011 868 $6K
82550 982 842 $6K
87086 Culture, bacterial; quantitative colony count, urine 650 532 $6K
85610 869 706 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 127 116 $5K
87081 601 472 $4K
83880 188 159 $4K
73030 240 192 $4K
96375 Therapeutic injection; each additional sequential IV push 1,560 1,347 $4K
84703 545 389 $4K
87040 357 228 $4K
82962 484 286 $4K
80050 General health panel 89 84 $3K
73562 134 96 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 496 421 $3K
85730 632 500 $3K
12011 13 12 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 15 15 $2K
87807 193 185 $2K
87486 53 52 $2K
87581 53 52 $2K
83605 318 246 $2K
70486 12 12 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,437 2,124 $2K
72100 77 64 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination 138 107 $2K
80306 138 123 $2K
72125 Computed tomography, cervical spine; without contrast material 18 16 $2K
84443 Thyroid stimulating hormone (TSH) 171 143 $2K
82077 99 89 $2K
0225U 411 391 $2K
97162 12 12 $2K
99284 Emergency department visit for the evaluation and management, high severity 378 352 $1K
80320 143 113 $1K
87186 244 200 $1K
87077 141 130 $1K
96376 153 117 $1K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 85 79 $1K
97161 17 13 $1K
82553 144 82 $955.84
99282 Emergency department visit for the evaluation and management, low to moderate severity 31 28 $926.49
94664 965 848 $898.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 12 12 $672.61
73560 15 13 $617.54
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 849 748 $493.91
86677 35 28 $435.12
82803 18 17 $423.60
87420 34 33 $411.84
J7030 Infusion, normal saline solution , 1000 cc 1,370 1,155 $383.88
J2550 Injection, promethazine hcl, up to 50 mg 559 465 $347.78
J7120 Ringers lactate infusion, up to 1000 cc 825 684 $340.07
0202U Oncology (prostate), multianalyte, gene expression profiling 121 110 $335.00
90714 49 38 $327.37
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 488 403 $285.94
90715 15 14 $272.21
74018 13 12 $263.38
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 86 72 $249.66
85379 27 26 $238.06
73140 16 12 $224.00
88312 88 66 $175.06
J2270 Injection, morphine sulfate, up to 10 mg 922 774 $145.68
80329 17 13 $136.26
J1170 Injection, hydromorphone, up to 4 mg 823 678 $119.82
85007 41 35 $114.49
81015 105 104 $68.61
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 349 337 $63.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 122 102 $59.98
J2704 Injection, propofol, 10 mg 208 165 $59.33
82248 12 12 $57.36
82947 20 13 $39.20
J0780 Injection, prochlorperazine, up to 10 mg 62 59 $26.02
J1040 Injection, methylprednisolone acetate, 80 mg 13 12 $16.88
J2060 Injection, lorazepam, 2 mg 15 12 $13.92
J2919 Injection, methylprednisolone sodium succinate, 5 mg 197 173 $4.31
J2765 Injection, metoclopramide hcl, up to 10 mg 12 12 $3.95
J3010 Injection, fentanyl citrate, 0.1 mg 55 40 $3.66
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 13 12 $2.07
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 71 63 $0.12
J7050 Infusion, normal saline solution, 250 cc 873 588 $0.00
A9270 Non-covered item or service 538 218 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 147 127 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 34 25 $0.00
36600 18 17 $0.00
J1644 Injection, heparin sodium, per 1000 units 88 42 $0.00